You're reading the free version. Trader adds the live tape and alerts.
Start tracking
OTLC Award Disclosure
Fein Seymour Howard · SEC Form 4 · Filed Jul 23, 2026
Award
Calculated transaction value
$0
Fein Seymour Howard CRO/CMO
OTLC
Transaction date
Jul 10, 2026
Public filing date
Jul 23, 2026
Filing lag
Filed 13 days later
OTLC daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted stock Units on Series A Preferred Stock
- Quantity / price
- 250 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001493152-26-034397
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Oncotelic Therapeutics, Inc. OTLC Current | Award | Jul 10, 2026 | $0 |